MAMMOLOGIX

Why Your Facility Needs Policy 1.02:

Interpreting Physician Continuing Qualifications

A Guide for Mammography Facilities Committed to Compliance, Quality, and Patient Safety

Why this policy exists

Policy 1.02 exists because mammography quality depends not only on equipment, image acquisition, reporting language, and follow-up systems, but also on the continued readiness of the physician interpreting the mammogram. A physician may have been properly qualified at one point in time, but MQSA requires continued evidence of experience, continuing education, and modality-specific training before the physician continues independent mammography interpretation. Policy 1.02 turns that federal requirement into a practical facility safeguard: no independent mammography interpretation without verified current qualification or documented reestablishment after a lapse.

The policy is rooted in the original MQSA purpose. FDA's Federal Register history explains that MQSA was enacted to establish national quality standards for mammography and to require accreditation and certification for facilities providing mammography services. The standards were intended to replace the prior "patchwork" of federal, state, and private standards so that women nationwide would receive high-quality mammography services.

Why initial qualification is not enough

The central issue addressed by Policy 1.02 is that initial qualification does not permanently prove current readiness. The 1997 MQSA final rule required interpreting physicians to maintain qualifications through ongoing experience and education. Specifically, after the applicable anniversary period, an interpreting physician must have interpreted or multi-read at least 960 mammographic examinations during the applicable 24-month period, and must have taught or completed at least 15 Category I CME credits in mammography during the applicable 36-month period. The rule also requires at least six Category I CME credits in each mammographic modality used and at least eight hours of training before independently interpreting a new mammographic modality.

That is why Policy 1.02 is not simply a credentialing policy. It is a continuing qualification policy. It requires the facility to keep asking: Does this physician still meet the federal experience requirement? Does this physician still meet the federal CME requirement? Is modality-specific training documented? Is the official MQSA measurement date selected and applied consistently? If those answers are not documented, the facility cannot safely treat the physician as currently authorized under the policy.

Why the policy must be operational, not theoretical

A federal requirement only protects patients if the facility has a working process to apply it. Policy 1.02 therefore assigns responsibility to the Lead Interpreting Physician, Facility Administrator or MQSA Responsible Individual, Credentialing Coordinator, and each Interpreting Physician. The policy requires tracking, documentation, quarterly monitoring, early warning, lapse review, reestablishment documentation, and written authorization before independent interpretation resumes.

This operational structure reflects the broader MQSA quality assurance framework. The 1997 final rule required each facility to establish and maintain a quality assurance program to ensure the safety, reliability, clarity, and accuracy of mammography services. It also required responsibility for the quality assurance program and its elements to be assigned to qualified individuals, with the Lead Interpreting Physician having general responsibility for ensuring that the QA program meets the requirements of the rule.

Why reestablishing qualifications matters

Policy 1.02 is especially important when a physician falls below the continuing experience or continuing education threshold. Under the 1997 final rule, interpreting physicians who fail to maintain the required continuing experience or education must reestablish qualifications before resuming independent interpretation. For an experience lapse, the physician must either interpret or multi-read at least 240 mammographic examinations under direct supervision, or complete enough supervised examinations to bring the physician's prior 24-month total to 960, whichever is less. These supervised interpretations must occur within the six months immediately before independent interpretation resumes.

For a CME lapse, the physician must obtain enough additional Category I mammography CME credits to bring the physician's total to the required 15 credits in the previous 36 months before resuming independent interpretation. Policy 1.02 correctly treats these as separate pathways: supervised interpretation does not substitute for CME, and CME does not substitute for supervised experience.

Why temporary, contracted, and teleradiology physicians must be included

Policy 1.02 applies to all physicians who independently interpret mammograms for the facility, including employed physicians, contracted radiologists, locum tenens physicians, temporary coverage physicians, teleradiology physicians, and physicians returning after a leave of absence or interruption in mammography practice.

This matters because MQSA responsibility does not disappear when interpretation is performed through a contract or remote reading arrangement. A verbal assurance, staffing agreement, or historical credentialing record is not the same as current qualification evidence. The facility needs documentation showing that the physician meets the applicable continuing experience, CME, licensure, and modality training requirements before the physician interprets mammograms independently for that facility.

Why the Federal Register history matters

The Federal Register history shows that MQSA is built in layers. The 1997 final rule established the comprehensive quality standards that included interpreting physician continuing qualifications and reestablishment requirements. The 1998 correcting amendment clarified and corrected errors in the 1997 rule, explaining that some typographical and textual problems could have caused significant unintended consequences if left uncorrected. The 1999 rule addressed a conflict between MQSA mammography regulations and FDA electronic product radiation control performance standards, while again reaffirming the MQSA goal of uniform, high-quality mammography services.

The 2023 MQSA Final Rule continued that pattern of modernization rather than replacement. FDA stated that high-quality mammography requires qualified technologists, properly functioning equipment, interpretation by qualified physicians, and clear and prompt communication of results. FDA also stated that the MQSA implementing regulations address personnel qualifications, equipment standards, quality assurance, recordkeeping, reporting, communication of results, and clinical image review.

This is why Policy 1.02 must be tied to the actual current regulatory text, while still understanding the historical rulemaking path. The foundational interpreting physician qualification rules remain central, even as later Federal Register actions modernize or correct other parts of the MQSA framework.

Why this policy protects the facility

Policy 1.02 protects the facility from three common failures.

First, it prevents assumption-based credentialing, where a physician is scheduled because they are known, trusted, contracted, or historically qualified, but current MQSA evidence has not been verified.

Second, it prevents measurement-period errors, where experience or CME is reviewed informally without documenting the official MQSA measurement date permitted by regulation.

Third, it prevents unsafe return-to-practice decisions, where a physician returns after a gap, leave, low-volume period, or CME deficiency without first completing the required review or reestablishment pathway.

Why this policy protects patients

For patients, the policy serves a simple purpose: the person interpreting the mammogram should be currently qualified to do so. Mammography is a quality-dependent service. The 2023 Final Rule states that patients receive the full benefit of mammography only when the service is high quality, including interpretation by qualified physicians and clear, prompt communication of results.

That makes physician continuing qualification a patient-care issue, not merely a personnel-file issue. If interpretation is performed by a physician whose current qualifications are missing, lapsed, or unverifiable, the facility may face more than an inspection finding. It may face uncertainty about whether affected examinations require review, re-interpretation, patient notification, referring-provider notification, accreditation consultation, FDA/MQSA consultation, or other corrective action. Policy 1.02 addresses that risk directly by requiring immediate suspension of independent interpretation when current qualification cannot be verified and by requiring corrective action when unauthorized interpretation is discovered.

Bottom line

Policy 1.02 exists because MQSA qualification is not a one-time achievement. It is a continuing condition of independent mammography interpretation.

The policy's practical rule is clear: verify the physician, verify the experience, verify the CME, verify modality training, document the measurement period, and stop independent interpretation when qualification cannot be confirmed. That is the bridge between the Federal Register's quality framework and the daily operational reality of a breast imaging practice.